anti-HCV.
Characterization of a novel class of anti-HCV agents targeting protein-protein interactions
... similar anti-HCV HTS ...culture-derived HCV at low multiplicities of infection and averaged a therapeutic index of roughly 16 within its 18 or so ...full-length HCV genomes indiscriminate of ...
123
en fr Development of novel nanovehicles for anti-HCV/HCC therapies Développement de nouveaux nanovecteurs pour les thérapies anti-HCV/HCC
... Removal of the underlying SiO 2 template from the BrIBAM-HSA coated particles after each coating step (n = 2!5) yielded homogeneous and well-dispersed BrIBAM- protein hollow capsules wit[r] ...
213
New anti-HCV agents in the pipeline
... with HCV genotype 1 have improved dramatically to reach approximately ...identify HCV infected patients in the general population and to facilitate access to ...
2
Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.: Non invasive fibrosis indexes in HIV-HCV coinfected patients
... start anti-HCV treatment for this ...in HCV monoinfected patients, including the aspartate aminotransferase (AST) to platelet ratio index (17), the Forns index (18) and platelet count ...in ...
24
Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort
... of HCV infection and SVR, could be related to a lack of ...any HCV-related ...direct-acting anti-HCV drugs, further research is needed to determine whether suppression of HCV ...
12
HCV entry and neutralizing antibodies: lessons from viral variants.
... a HCV variant isolated from a well characterized patient with chronic HCV infection, and located outside the CD81 binding region of E2, was characterized by a decreased infectivity and decreased sensitivity ...
6
Study of HCV and HIV infections in Mali: Comparative Epidemiology and Risk Factors
... and HCV infections and to develop prevention means by documenting risk ...for HCV) were used to quantify the infections ...prevalences anti-HCV (0.2%) and HCV-RNA ...between HCV ...
1
Use of a HCV patients' education tool: the knowledge questionnaire with confidence degrees
... Figure 2: Patients’s compliance The introduction of all Direct-Acting Antiviral (DAA) based therapy for chronic Hepatitis C Virus (HCV) has dramatically changed HCV treatment paradigms and promises ...
1
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection
... T2/late HCV-speci fic CD8+ T ...between HCV-specific CD8+ T cells from established chronic and late- resolved ...resolved HCV patients and healthy FLU controls, confirmed the expression trends revealed ...
21
Anti-comonotone random variables and anti-monotone risk aversion
... Two random variables are comonotone if they move in the same directions. The notion of comonotonicity can be of great use for finance, insurance and actuarial issues since it can lead to an increase of the risk of a ...
30
Anticorps anti-NR1 dans l’encéphalite anti-récepteur N-méthyl-D-aspartate et la schizophrénie
... Rupture de tolérance aux molécules du soi Plusieurs mécanismes peuvent expliquer la rupture de tolérance aux molécules du soi dans les encéphalites anti-R-NMDA (Figure 2) . L’analyse histologique des tératomes ...
8
New pandemics: HIV and AIDS, HCV and chronic hepatitis, Influenza virus and flu
... that several treatment strategies can limit the develop- ment of resistance. Prevention Julie Bruneau (Centre de Recherche du CHUM, Univer- sité de Montréal, Canada) focused her presentation on harm reduction strategies ...
9
Anti-bubble generator
... form anti-bubbles. However, such a method for generat- ing anti-bubbles requires high cleanliness of the liquid surface, the survival rate of the anti-bubbles being very low, and the yield being very ...
12
SCARB1 variants and HCV infection: Host susceptibility is lost in translation
... that HCV infection could in itself account for these evolutionary selective pressures on SCARB1, the mechanisms underlying the genetic variation of SCARB1 could provide further insight into HCV-host ...
11
Role of community-based research in advocating HCV prevention and care
... There are several important examples of how community- based research has contributed to change health policy in France. These include ANRS DRAG, which promoted commu- nity-based testing as a tool to attract most-at-risk ...
3
Antiviral therapy in hemodialyzed HCV patients: efficacy, tolerance and treatment strategy
... to those related to HCV infection. The 2 patients who died in the present study suffered from such co-morbidities: one patient had cirrhosis and the other was 73-years-old. Although we cannot formally exclude the ...
27
Papisme - anti-papisme
... 1 Papisme – antipapisme Grégory Woimbée A l’origine, les anti-papistes sont les ennemis des papistes parce qu’ils sont les amis du Pape. Les hommes d’un même lieu et d’une même époque se divisent et la question ...
4
Dark anti-atoms
... Radiative capture of thermal dark anti-atoms by atoms of the active medium:. E ~ T d E1[r] ...
25
[Anti-EGFR and anti-HER2 monoclonal antibodies against pancreatic carcinomas]
... d’anticorps anti-EGFR et anti-HER2 : Efficacité pré-clinique dans le traitement du cancer du pancréas Christel Larbouret, Bruno Robert, Isabelle Teulon, David Azria, André Pèlegrin Centre de Recherche en ...
5
Proton-proton, anti-proton-anti-proton, proton-anti-proton correlations in Au + Au collisions measured by STAR at RHIC
... and anti-protons: p − p, p − p and p − p for the first time creating a complex description of proton inter- ferometry for various centralities and collision ...
7